Orient Technologies Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32

Regulatory & Legal View source PDF Explain this filing

ORIENTTECH · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-10.0%Reaction day

₹332.60

prior close

₹293.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.7%-9.2% vs market

IT Enabled Services peers, median of 71sector-1.4%-8.5% vs sector

On the reaction day the stock moved 9.2 pts less than Nifty Microcap 250 and 8.5 pts less than its IT Enabled Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+3.5

10m

+3.1

15m

+2.6

30m

+2.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-10.0-0.7-9.2-1.4-8.5

Next day

-11.7+0.2-12.0-0.3-11.5

-5.1+0.5-5.6-0.0-5.0

-3.8-0.9-2.9-2.2-1.6

-7.0-1.0-5.9-2.2-4.8

-8.0-0.9-7.1-2.4-5.6

-10.1-2.0-8.2-4.9-5.3

15d

-18.4-6.9-11.5-9.0-9.4

-21.4-10.5-10.9-13.3-8.1

-13.9+1.5-15.4-2.8-11.1

-20.3+3.8-24.2-6.9-13.4

UpDownMarket · Nifty Microcap 250Sector · IT Enabled Services peers, median of 71Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Orient Technologies has filed a quarterly compliance report on the use of its IPO proceeds (raised in August 2024, gross fresh issue of Rs. 120 crore). The company has confirmed that there is NO deviation or variation in the stated objects of the IPO. Out of the total Rs. 120 crore allocated across four purposes, Rs. 54.42 crore was utilized during the quarter. The office premise acquisition in Navi Mumbai (Rs. 10.35 crore) and general corporate purposes (Rs. 17.93 crore) are fully deployed, while issue expenses stand at Rs. 7.73 crore of the Rs. 12.07 crore budgeted. The largest gap remains capital expenditure, where only Rs. 18.41 crore of the Rs. 79.65 crore earmarked has been used so far (~23%). CARE Ratings Limited continues as the monitoring agency.

Likely market impact

This is a routine, non-event regulatory disclosure. No deviation means the company is using IPO funds in line with what was promised in the prospectus. However, the slow deployment of the Rs. 79.65 crore earmarked for capital expenditure (only ~23% used) is worth tracking, as it may raise questions about growth plans or timing, but it is not a red flag at this stage.